Why the study?
Cyclophosphamide is an effective anti-tumor agent for neoplastic diseases, but its use is associated with cardiotoxicity, prompting investigation into the protective role of vitamin E.
Does vitamin E prevent cyclophosphamide-induced cardiotoxicity in male Wistar rats?
Does vitamin E prevent cyclophosphamide-induced cardiotoxicity in male Wistar rats?
Vitamin E demonstrates a protective effect against cyclophosphamide-induced cardiotoxicity in a rat model through antioxidant mechanisms.
May warrant preclinical follow-up on vitamin E cardioprotection; leaves open any role in patients receiving cyclophosphamide.
No takes yet. Share an insight, caveat, or question.
Attia et al. (2023) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: